Mira Dx is a genomics company dedicated to the development and commercialization of novel microRNA-based diagnostic tests. The company's goal is to help clinicians better understand cancer and enhance decision making.
Funding Rounds (1) - $4MUpdate
|Oct 31, 2010||Mass Device - Mira Dx raises 4000000 in venture round|
300 George Street
New Haven, CT 06511